AMIX Market Analysis
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio—
EPS (TTM)$-48.720.0% YoY
Profit margin0.0%HEALTHCARE
Market cap$1.9MMicro cap
Valuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- 0.31
- P/S (TTM)
- —
- EV/EBITDA
- —
Profitability & growth
- ROE (TTM)
- -238.9%
- Operating margin
- 0.0%
- Revenue growth YoY
- 0.0%
- Dividend yield
- —
- Beta
- -1.30
Last earnings
Jun 4, 2026 · Estimate $-5.46 · Reported $-0.23
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Autonomix Medical, Inc. Common Stock
Company profileAutonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company is headquartered in The Woodlands, Texas.
Classification
- Sector
- Healthcare
- Industry
- Medical Devices
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 21 WATERWAY AVENUE, THE WOODLANDS, TX
- Fiscal year end
- March
- Latest quarter
- Mar 31, 2026
Market cap$1.9M
Shares outstanding$543000
52W high$32.55
52W low$2.44
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent